None listed
Conditions
Interventions
Intervention1: Face Cleanser: Cleansing face with standard cleanser.
1 ml of test product will be used as cleanser twice a day starting from Day 01 to Day 28.
Application of neutral moisturizer post
Sponsors
LOréal India Pvt. Ltd.
Eligibility
Inclusion criteria
Inclusion criteria: 1) Subjects with skin phototype III - V (Fitzpatrick phototype assessed based on ITA value) 2) Subjects having Body Mass Index in the range of 18 to 25 kg/m2. 3) Subjects having oily skin type and combination of oily, sensitive. 4) Subjects with mild to moderate acne severity based on IGA scale. 5) Subjects with PIH spot of 3mm & above. 6) Subjects presenting acne lesions count: • more than/equal to 10 to less than/equal to 25 inflammatory acne lesions on whole face • more than 25 to less than/equal to 100 non-inflammatory acne lesions on whole face
Exclusion criteria
Exclusion criteria: 1) Subjects who have used anti acne products in the last 30 days. 2) Subjects who are receiving topical or systemic treatments for acne and PIH within last 30 days. 3) Subjects undergoing dermatological procedures for skin lightening or using other marketed skin lightening products during the study period or in the past 6 weeks. 4) Subjects having any active dermatological skin diseases (e.g., psoriasis, atopic dermatitis, rosacea etc.), that might interfere with clinical assessments. 5) Subject having excessive hair, moles, open wounds, cuts, abrasions, irritation symptoms, tattoos, scars, sunburn or any dermatological condition on the test site(s) that can interfere with the reading.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Dermatological assessment of acne lesions using counting method. 2) Instrumental assessment of intensity of PIH and bare skin. 3) Instrumental assessment of the size of PIHTimepoint: Screening Visit, Day 01, Day 03, Day 07, Day 14, Day 28 and Day 42. | — |
Secondary
| Measure | Time frame |
|---|---|
| Dermatological assessment of Acne Severity using grading scaleTimepoint: Screening Visit, Day 01, Day 03, Day 07, Day 14, Day 28 and Day 42.;Dermatological assessment of Redness around Acne lesion and skin radiance using grading scaleTimepoint: Day 01, Day 03, Day 07, Day 14, Day 28 and Day 42;Instrumental assessment of skin sebum level, face hydration, skin barrier function and skin brighteningTimepoint: Day 01, Day 03, Day 07, Day 14, Day 28 and Day 42;Instrumental assessment of Redness around acne (a value & redness measurements), acne elevation & sebaceous poresTimepoint: Screening Visit, Day 01, Day 03, Day 07, Day 14, Day 28 & Day 42.;Dermatological assessment of global efficacy and tolerance of productsTimepoint: Day 03, Day 07, Day 14, Day 28 and Day 42.;Subjective assessmentTimepoint: Day 01, Day 03, Day 07, Day 14, Day 28 and Day 42. | — |
Countries
India
Contacts
Public ContactDr Parth Joshi
Cliantha Research
Outcome results
None listed